(Q42205169)

English

Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort

scientific article published on 15 July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

liver cirrhosis

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

George Papatheodoridis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

S Manolakopoulos

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

G Touloumi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

G Nikolopoulou

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

M Raptopoulou-Gigi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

C Gogos

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

I Vafiadis-Zouboulis

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

D Karamanolis

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

A Chouta

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

A Ilias

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

C Drakoulis

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

K Mimidis

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

I Ketikoglou

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

E Manesis

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

M Mela

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

G Hatzis

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

G N Dalekos

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

HepNet.Greece Study Group

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

15 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

120-127

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12283

21 January 2018

Identifiers

10.1111/JVH.12283

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040685%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42205169&oldid=1935937040"